Table 2.
Key words | India | Pakistan | Bangladesh | Nepal | Sri Lanka | Maldives | |
PubMed - Retrieved | Injection and country/state | 189 | 51 | 12 | 14 | 13 | 5 |
PubMed - selected/relevant | 25 | 25 | 5 | 8 | 0 | 0 | |
Google Scholar1 | Unsafe injections, injections, country | 3 | 1 (419) | 2 (329) | 1 (242) | 0 (40) | |
Unsafe injections, injections, country | 2 | 1 | 0 | 0 | |||
WHO website | 0 | 0 | 0 | 0 | 0 | 0 | |
PATH | 2 | ||||||
In country assessments by MoH | 1 | ||||||
Unpublished reports | 1 | 2 | |||||
Other circumstantial evidence2 | |||||||
Risk factors studies suggesting injection use | Risk factors, HBV (HCV), country | 1 | |||||
Hepatitis B/C | Hepatitis B, Hepatitis C, Country | 19 (38) | 13 (36) | ||||
Health care utilization | Health care seeking, Health care utilization, Private practice, Country | 15 (32) | 6 (16) | ||||
(retrieved) | |||||||
Private practitioners health seeking (retrieved) | Health care seeking, Private practice, Country | 5 (8) | 3 | ||||
Prescribing practices (retrieved) | Prescription practices, Country | 5 (5) | 1 |
Google scholar retrieved too many articles and most of them were not relevant: these were used mainly for countries for which information was not available through PubMed;
Not used for countries for which data on injection use were available. Parenthesis represent retrieved and number represent the number that were relevant and reviewed. HBV: Hepatitis B virus; HCV: Hepatitis C virus.